Stock Price
1.44
Daily Change
-0.02 -1.37%
Monthly
-4.64%
Yearly
-22.99%
Q1 Forecast
1.41

Autolus Therapeutics Ltd reported $34.11M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.61B 4.46B Dec/2025
Autolus Therapeutics Ltd USD 34.11M 6.16M Sep/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Silence Therapeutics USD 5.6M 312K Sep/2024